Tet1 deficiency exacerbates oxidative stress in acute kidney injury by regulating superoxide dismutase

Rationale: Increased methylation of key genes has been observed in kidney diseases, suggesting that the ten-eleven translocation (Tet) methyl-cytosine dioxygenase family as well as 5mC oxidation may play important roles. As a member of the Tet family, the role of Tet1 in acute kidney injury (AKI) remains unclear. Methods: Tet1 knockout mice, with or without tempol treatment, a scavenger of reactive oxygen species (ROS), were challenged with ischemia and reperfusion (I/R) injury or unilateral ureteral obstruction (UUO) injury. RNA-sequencing, Western blotting, qRT-PCR, bisulfite sequencing, chromatin immunoprecipitation, immunohistochemical staining, and dot blot assays were performed. Results: Tet1 expression was rapidly upregulated following I/R or UUO injury. Moreover, Tet1 knockout mice showed increased renal injury and renal cell death, increased ROS accumulation, G2/M cell cycle arrest, inflammation, and fibrosis. Severe renal damage in injured Tet1 knockout mice was alleviated by tempol treatment. Mechanistically, Tet1 reduced the 5mC levels in an enzymatic activity-dependent manner on the promoters of Sod1 and Sod2 to promote their expression, thus lowering injury-induced excessive ROS and reducing I/R or UUO injury. Conclusions: Tet1 plays an important role in the development of AKI by promoting SOD expression through a DNA demethylase-dependent mechanism.

[1]  Dong Yang,et al.  An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Anlin Peng,et al.  A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury , 2023, Nature communications.

[3]  Chengyu Liu,et al.  Linker histone variant H1.2 is a brake on white adipose tissue browning , 2023, Nature communications.

[4]  R. Petersen,et al.  Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation , 2023, Theranostics.

[5]  Dong Yang,et al.  Loss of renal tubular G9a benefits acute kidney injury by lowering focal lipid accumulation via CES1 , 2023, EMBO reports.

[6]  M. Savitski,et al.  Control of protein stability by post-translational modifications , 2023, Nature Communications.

[7]  Elizabeth H. Chen,et al.  YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis , 2022, Nature Genetics.

[8]  Z. Dong,et al.  Inflammation in kidney repair: Mechanism and therapeutic potential. , 2022, Pharmacology & therapeutics.

[9]  Qian Wang,et al.  Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver , 2022, Nature Communications.

[10]  Chengyu Liu,et al.  Mecp2 protects kidney from ischemia-reperfusion injury through transcriptional repressing IL-6/STAT3 signaling , 2022, Theranostics.

[11]  Yuyan Sun,et al.  Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling , 2022, Cancer Science.

[12]  Hong Chen,et al.  Histone demethylase UTX aggravates acetaminophen overdose induced hepatotoxicity through dual mechanisms. , 2021, Pharmacological research.

[13]  Yuanyuan Fu,et al.  A-Lipoic Acid Alleviates Folic Acid-Induced Renal Damage Through Inhibition of Ferroptosis , 2021, Frontiers in Physiology.

[14]  Guangtao Xu,et al.  Allicin ameliorates renal ischemia/reperfusion injury via inhibition of oxidative stress and inflammation in rats. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Chengyu Liu,et al.  Vitamin C Inhibits the Metabolic Changes Induced by Tet1 Insufficiency Under High Fat Diet Stress. , 2021, Molecular nutrition & food research.

[16]  J. Pedraza-Chaverri,et al.  Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis. , 2021, Free radical biology & medicine.

[17]  Yizhuo Wang,et al.  Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance , 2021, Theranostics.

[18]  Wenjuan Wang,et al.  TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1. , 2020, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  A. Vijayan Tackling AKI: prevention, timing of dialysis and follow-up , 2020, Nature Reviews Nephrology.

[20]  X. Lan,et al.  PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury. , 2020, Journal of medicinal chemistry.

[21]  R. Petersen,et al.  Muscular G9a Regulates Muscle-Liver-Fat Axis by Musclin Under Overnutrition in Female Mice , 2020, Diabetes.

[22]  Ying Yao,et al.  XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury , 2020, Cell Death & Disease.

[23]  Xiaoqiang Ding,et al.  Hydrogen sulfide attenuates renal fibrosis by inducing TET‐dependent DNA demethylation on Klotho promoter , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  J. Cang,et al.  Ten-eleven translocation methyl-cytosine dioxygenase 2 deficiency exacerbates renal ischemia-reperfusion injury , 2020, Clinical Epigenetics.

[25]  Rongqian Wu,et al.  Involvement of GPX4 in irisin's protection against ischemia reperfusion‐induced acute kidney injury , 2020, Journal of cellular physiology.

[26]  Jiucun Wang,et al.  TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter , 2020, Nutrition & Metabolism.

[27]  R. Petersen,et al.  Multi-generational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. , 2020, Journal of hepatology.

[28]  Guian Huang,et al.  Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation , 2020, iScience.

[29]  Zhongbo Zhang,et al.  Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice , 2020, International journal of biological sciences.

[30]  M. Ehrlich DNA hypermethylation in disease: mechanisms and clinical relevance , 2019, Epigenetics.

[31]  Xiujing Feng,et al.  Dexmedetomidine Ameliorates Acute Stress-Induced Kidney Injury by Attenuating Oxidative Stress and Apoptosis through Inhibition of the ROS/JNK Signaling Pathway , 2018, Oxidative medicine and cellular longevity.

[32]  M. Abdel-Bakky,et al.  Tempol, a superoxide dismutase mimetic agent, reduces cisplatin-induced nephrotoxicity in rats , 2018, Drug and chemical toxicology.

[33]  D. Nakano,et al.  Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response , 2018, Current opinion in nephrology and hypertension.

[34]  L. Pnueli,et al.  Tet Enzymes, Variants, and Differential Effects on Function , 2018, Front. Cell Dev. Biol..

[35]  A. Resende,et al.  Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats , 2018, Clinical and experimental hypertension.

[36]  Juan Du,et al.  Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity , 2017, Nucleic acids research.

[37]  Hong Chen,et al.  ELABELA and an ELABELA Fragment Protect against AKI. , 2017, Journal of the American Society of Nephrology : JASN.

[38]  P. Bhargava,et al.  Mitochondrial energetics in the kidney , 2017, Nature Reviews Nephrology.

[39]  Jinu Kim Poly(ADP-ribose) polymerase activation induces high mobility group box 1 release from proximal tubular cells during cisplatin nephrotoxicity. , 2016, Physiological research.

[40]  Hui-ping Wang,et al.  Protective Effect of Tempol on Acute Kidney Injury Through PI3K/Akt/Nrf2 Signaling Pathway , 2016, Kidney and Blood Pressure Research.

[41]  F. Ciccarone,et al.  5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme , 2015, Oncotarget.

[42]  J. Bonventre,et al.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD , 2015, Nature Reviews Nephrology.

[43]  Xian Chen,et al.  CRL4(VprBP) E3 ligase promotes monoubiquitylation and chromatin binding of TET dioxygenases. , 2015, Molecular cell.

[44]  Zilong Qiu,et al.  Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress , 2015, Scientific Reports.

[45]  Qiang Shu,et al.  From development to diseases: the role of 5hmC in brain. , 2014, Genomics.

[46]  R. Kalluri,et al.  Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis. , 2014, Journal of the American Society of Nephrology : JASN.

[47]  C. Franceschi,et al.  Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription , 2014, Oncotarget.

[48]  M. Sánchez-Niño,et al.  Unilateral ureteral obstruction: beyond obstruction , 2014, International Urology and Nephrology.

[49]  Yi Zhang,et al.  TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.

[50]  Dan Liu,et al.  Ten-Eleven Translocation 1 (Tet1) Is Regulated by O-Linked N-Acetylglucosamine Transferase (Ogt) for Target Gene Repression in Mouse Embryonic Stem Cells* , 2013, The Journal of Biological Chemistry.

[51]  V. Demarco,et al.  Mineralocorticoid Receptor-Dependent Proximal Tubule Injury Is Mediated by a Redox-Sensitive mTOR/S6K1 Pathway , 2011, American Journal of Nephrology.

[52]  Peng Jin,et al.  5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging , 2011, Nature Neuroscience.

[53]  D. Page,et al.  Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. , 2011, Cell stem cell.

[54]  Li Yang,et al.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury , 2010, Nature Medicine.

[55]  S. Kiley,et al.  Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy , 2010, Pediatric Nephrology.

[56]  M. Rosner,et al.  Acute kidney injury. , 2009, Current drug targets.

[57]  B. Padanilam,et al.  Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. , 2005, Pharmacological research.

[58]  R. Kalluri,et al.  Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression. , 2017, Kidney international.